Pomalid Capsules in Singapore | Uses, Strengths & Benefits

Pomalid Capsules contain pomalidomide, an immunomodulatory medicine used in specialist oncology care. Pomalidomide is prescribed for certain patients with multiple myeloma, a type of blood cancer, according to the applicable approved product information and treatment guidelines.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information for healthcare professionals, distributors and international pharmaceutical trade partners. For enquiries concerning Pomalid Capsules in Singapore, product documentation, manufacturer details, packaging specifications and regulatory status should be verified before any supply arrangement.

Pomalid Capsules Strengths

Pomalidomide capsules are available in different strengths in various markets, commonly including:

Pomalidomide 1 mg capsules

Pomalidomide 2 mg capsules

Pomalidomide 3 mg capsules

Pomalidomide 4 mg capsules

Important: The availability of these strengths under the Pomalid brand must be confirmed against the actual product catalogue and packaging supplied by Cordium Pharmaceuticals Pvt Ltd. Availability does not establish registration or authorisation for sale in Singapore.

What Is Pomalidomide Used For?

Pomalidomide is used in the treatment of selected cases of multiple myeloma. Depending on the applicable product approval, it may be prescribed alongside other medicines for eligible patients whose disease has progressed after previous treatments.

The treatment regimen depends on the patient's medical history, previous therapies, clinical condition and the relevant prescribing information. Pomalidomide is not suitable for self-medication and should be prescribed and monitored by an appropriately qualified specialist.

Potential Clinical Benefits

When prescribed for an approved indication, pomalidomide may contribute to a combination treatment plan designed to manage multiple myeloma. Potential treatment outcomes depend on the patient's condition, the accompanying medicines and individual response.

Clinical considerations include:

Combination therapy: May be used with other medicines under an approved treatment protocol.

Specialist-directed treatment: Enables an individualised approach to selected patients with multiple myeloma.

Treatment monitoring: Regular medical assessments help clinicians evaluate response and identify adverse effects.

These are general characteristics of pomalidomide therapy, not guarantees of outcomes for an individual patient.

Side Effects and Safety Information

Pomalidomide can cause serious adverse effects. Commonly reported effects include fatigue, constipation, nausea, anaemia, reduced blood-cell counts and respiratory infections. Serious risks may include blood clots, severe infections and fetal harm.

Pomalidomide is highly teratogenic and requires strict pregnancy-prevention precautions. Patients must follow the applicable risk-management programme and specialist instructions. Blood tests and clinical monitoring may be required throughout treatment.

Patients should report unusual bleeding, fever, breathing difficulties, chest pain or leg swelling promptly to their healthcare team. This information does not replace the approved product insert or professional medical advice.

Frequently Asked Questions (FAQs)

1. What is the active ingredient in Pomalid Capsules?

The active ingredient is pomalidomide, an immunomodulatory medicine used in specialist treatment of certain cases of multiple myeloma.

2. What strengths of Pomalid Capsules are available?

Pomalidomide is marketed in several strengths, commonly 1 mg, 2 mg, 3 mg and 4 mg. Confirm the exact strengths available under the Pomalid brand before publication or procurement.

3. Can Pomalid Capsules be taken without a prescription?

No. Pomalidomide requires specialist medical supervision and must be used in accordance with applicable prescription and regulatory requirements.

4. Is Pomalid registered in Singapore?

Registration status must be checked with Singapore's Health Sciences Authority (HSA). Do not assume that overseas availability authorises local sale.

5. How can healthcare professionals obtain product information?

Healthcare professionals and authorised pharmaceutical trade partners may contact Cordium Pharmaceuticals Pvt Ltd to request relevant product documentation, subject to applicable regulatory requirements.